Dr. Chana L. Glasser
Claim this profileNYU Winthrop Hospital
Studies Neuroblastoma
Studies Lymphoma
29 reported clinical trials
81 drugs studied
About Chana L. Glasser
Education:
- Earned an MD from the University of Medicine & Dentistry of New Jersey in 2009.
- Completed a Residency in Pediatrics at Mount Sinai School of Medicine in 2012.
- Finished a Fellowship in Pediatric Hematology/Oncology at New York-Presbyterian Hospital in 2015.
Experience:
- Serves as Clinical Associate Professor in the Department of Pediatrics at NYU Long Island School of Medicine.
- Holds the position of Division Chief of Pediatric Hematology and Oncology at NYU Langone Hospital – Long Island.
- Acts as Course Co-Director for the Hematology-Oncology System at NYU Long Island School of Medicine.
- Board Certified in Pediatric Hematology-Oncology (2017) and Pediatrics (2012) by the American Board of Pediatrics.
Area of expertise
1Neuroblastoma
MYC positive
Stage IV
MYC negative
2Lymphoma
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Chana L. Glasser is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Chana L. Glasser
Clinical Trial Related7 years of experience running clinical trials · Led 29 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Chana L. Glasser has experience with
- Cyclophosphamide
- Etoposide
- Vincristine Sulfate
- Doxorubicin Hydrochloride
- Methotrexate
- Radiation Therapy
Breakdown of trials Chana L. Glasser has run
Neuroblastoma
Lymphoma
Leukemia
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chana L. Glasser specialize in?
Chana L. Glasser focuses on Neuroblastoma and Lymphoma. In particular, much of their work with Neuroblastoma has involved MYC positive patients, or patients who are Stage IV.
Is Chana L. Glasser currently recruiting for clinical trials?
Yes, Chana L. Glasser is currently recruiting for 9 clinical trials in Mineola New York. If you're interested in participating, you should apply.
Are there any treatments that Chana L. Glasser has studied deeply?
Yes, Chana L. Glasser has studied treatments such as Cyclophosphamide, Etoposide, Vincristine Sulfate.
What is the best way to schedule an appointment with Chana L. Glasser?
Apply for one of the trials that Chana L. Glasser is conducting.
What is the office address of Chana L. Glasser?
The office of Chana L. Glasser is located at: NYU Winthrop Hospital, Mineola, New York 11501 United States. This is the address for their practice at the NYU Winthrop Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.